This week in IPOs — Holtec prices, Jio roadshows, Oura waits
Holtec Nuclear set terms this week, Jio Platforms began its global roadshow, and Oura's S-1 still has no price range — three stages, one pipeline.
An S-1 filing is not a single event — it's the start of a process that can take anywhere from a few weeks to well over a year, and most of the pipeline coverage that treats "filed" as the interesting moment misses everything that happens after. This week gave a clean look at three different points on that timeline at once: one deal setting final terms and heading into pricing, one beginning the investor roadshow that precedes it, and one still sitting on a public S-1 with no price range attached six days after filing. Watching all three side by side is a better way to understand deal mechanics than watching any single one in isolation.
Holtec Nuclear: terms set, pricing days away
Holtec Nuclear launched the roadshow for its IPO on September 8, offering 50 million Class A shares at a proposed $15 to $18 each — roughly $825 million at the midpoint, on the way to a targeted valuation of up to $10.2 billion when it lists on Nasdaq under ticker HNUC. J.P. Morgan, Guggenheim Securities, Goldman Sachs, Citigroup and BofA Securities lead a nine-bank syndicate, and pricing is expected within days of the roadshow's close.
What makes Holtec worth tracking is that it's a real business, not a story stock: it already generates revenue and profit, is leading the restart of the 800MW Palisades nuclear plant in Michigan with $400 million in DOE backing, and is developing its SMR-300 small modular reactor alongside that. The roadshow-to-pricing window is usually the shortest stretch in the whole IPO timeline — a matter of days, not months — because by the time a bank sets a specific price range and share count, most of the real due diligence and investor sounding has already happened privately. The mechanics of exactly how many extra shares underwriters can sell on top of that base offering are worth a closer look on their own; the greenshoe option explainer walks through why Holtec's over-allotment came in at exactly 7.5 million shares.
Jio Platforms: the roadshow before the roadshow
Jio Platforms is several steps further back in the process. Reliance Industries' telecom and digital-services arm received approval from India's securities regulator on August 28 and plans to begin international investor meetings as early as this week, with stops across the US, Singapore, Hong Kong, London and the Middle East ahead of a targeted November listing on the NSE and BSE. At a reported valuation range of $130–170 billion, it would be India's largest IPO ever — and the scale of the global roadshow reflects that: this isn't a single US-based bank tour but a multi-continent circuit designed to lock in anchor investors across several sovereign wealth funds and institutional pools before the domestic retail tranche even opens.
The gap between Jio's process and Holtec's is instructive. Holtec's roadshow is the final step before pricing, typically lasting one to two weeks. Jio's international roadshow is happening more than two months before its targeted listing window, because a deal of this size needs to build a much larger and more geographically dispersed order book before bankers can even propose a price range — the roadshow itself is partly the price-discovery mechanism, not just a formality after the price is already set. Investors interested in Jio's entry in the pipeline can watch that valuation range narrow as more concrete terms emerge over the coming weeks.
Oura: filed, and still waiting
Oura sits at a third stage entirely. The smart-ring maker filed a public S-1 for a Nasdaq listing on September 3, disclosing revenue up 74% to $1.21 billion and more than 5 million paying members — real numbers, in a real public filing. But as of this week, no price range, share count, or firm listing date has been set. Bloomberg has reported the company is targeting a raise of up to $3 billion at a valuation above $16 billion, but "targeting" and "reported" are doing real work in that sentence: nothing in Oura's own filing commits to those figures yet.
That's a normal and often lengthy stage. Companies frequently sit on a public S-1 for weeks while the SEC staff reviews the filing and comments come back, sometimes prompting amendments before a roadshow is ever scheduled. The public-S-1-without-a-price-range period can run anywhere from a couple of weeks to several months, and it's the stage most prone to a deal simply going quiet — either paused for market conditions or restructured before terms are set. Zorro's upcoming IPO tracker assigns Oura an 88% listing probability precisely because the filing itself is public and detailed, even without terms — a materially different confidence level than deals still sitting on confidential drafts.
Why the stage matters more than the headline
The lesson from stacking these three together: "IPO filed" tells you almost nothing about timing on its own. Holtec's roadshow-to-pricing gap is measured in days, Jio's international roadshow is running more than two months ahead of its target window, and Oura has already cleared the public-filing bar but has no scheduled pricing at all. A pipeline entry's probability and window estimate should reflect which of these stages a deal is actually in, not just whether a filing exists. Once any of these three converts from filed or roadshowing to actually priced and trading, it moves into a different kind of tracking — the kind covered for recently priced IPOs, where lockups, greenshoes, and first-quarter earnings start to matter more than the roadshow ever did.